BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2834854)

  • 1. [Position of surveillance therapy in clinical stage I testicular non-seminoma].
    Thon WF; Sparwasser C; Gilbert P; Altwein JE
    Urol Int; 1987; 42(6):445-9. PubMed ID: 2834854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
    Pizzocaro G; Zanoni F; Salvioni R; Milani A; Piva L; Pilotti S
    J Urol; 1987 Dec; 138(6):1393-6. PubMed ID: 2824862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003].
    Pizzocaro G; Schiavo M; Solima S; Vitellaro M; Biasoni N; Nicolai N
    Urologia; 2010; 77 Suppl 17():50-6. PubMed ID: 21308676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage I nonseminomatous germ cell tumor of the testis: more questions than answers?
    Powles T
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):517-27,viii. PubMed ID: 21570606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in clinical stage I nonseminomatous germ cell testicular tumors: rationale for different risk-adapted treatment.
    Ondrus D; Matoska J; Belan V; Kausitz J; Goncalves F; Hornák M
    Eur Urol; 1998; 33(6):562-6. PubMed ID: 9743698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of clinical stage I testicular germ cell tumours].
    Loriot Y; Fizazi K
    Bull Cancer; 2007 May; 94(5):439-48. PubMed ID: 17535781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical aspects in the treatment of patients with testicular cancer.
    Richie JP
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1127-42. PubMed ID: 1663937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is risk-oriented therapy in stage I non-seminoma tumor advisable?].
    Krege S; Rübben H
    Urologe A; 1993 May; 32(3):171-5. PubMed ID: 8390119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nonbulky nonseminomas: N-staging value of image-producing study procedures with reference to possible surveillance management].
    Tradowsky M; Bähren W; Egghart G; Altwein JE
    Urologe A; 1986 May; 25(3):160-3. PubMed ID: 3016966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease?
    Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M
    Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD; Foster RS; Bihrle R; Donohue JP
    Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience.
    Hyams ES; Pierorazio P; Proteek O; Sroka M; Kavoussi LR; Allaf ME
    J Urol; 2012 Feb; 187(2):487-92. PubMed ID: 22177913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
    Yoon GH; Stein JP; Skinner DG
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic parameters and their value in testicular tumors].
    Bürgler W; Jaeger P
    Urologe A; 1986 May; 25(3):157-9. PubMed ID: 3016965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)].
    Nicolai N; Necchi A; Piva L; Stagni S; Catanzaro MA; Biasoni D; Milani A; Torelli T; Salvioni R
    Urologia; 2010; 77(2):84-7. PubMed ID: 20890864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.